Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 12 2023 - 11:53AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2023
Commission File
Number 001-15170
GSK
plc
(Translation of
registrant's name into English)
980
Great West Road, Brentford, Middlesex, TW8 9GS
(Address of
principal executive office)
Indicate by check
mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc (the
'Company')
Transaction
notification
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Ms
E Walmsley
|
|
b)
|
Position/status
|
Chief
Executive Officer
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Mr
J Ford
|
|
b)
|
Position/status
|
SVP and
Group General Counsel, Legal and Compliance
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Ms
S Jackson
|
|
b)
|
Position/status
|
SVP,
Global Communications and CEO Office
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Mr
D Jackson
|
|
b)
|
Position/status
|
PCA of
Ms S Jackson (SVP, Global Communications and CEO
Office)
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
8
(partnership shares)
|
|
|
|
£14.5379
|
8
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
16
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Mr
D Redfern
|
|
b)
|
Position/status
|
President Corporate
Development
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Mr
R Simard
|
|
b)
|
Position/status
|
President, Global
Supply Chain
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Mr
P Thomson
|
|
b)
|
Position/status
|
President, Global
Affairs
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Ms
D Waterhouse
|
|
b)
|
Position/status
|
CEO,
ViiV Healthcare and President, Global Health, GSK
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
8
(partnership shares)
|
|
|
|
£14.5379
|
8
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
16
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|
a)
|
Name
|
Ms
V Whyte
|
|
b)
|
Position/status
|
Company
Secretary
|
|
c)
|
Initial
notification/amendment
|
Initial
notification
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GSK
plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|
a)
|
Description
of the financial instrument
|
Ordinary
shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:
GB00BN7SWP63
|
|
b)
|
Nature
of the transaction
|
Acquisition
of Ordinary Shares under the Company's Share Reward
Plan
|
|
c)
|
Price(s)
and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£14.5379
|
9
(partnership shares)
|
|
|
|
£14.5379
|
9
(matching shares)
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
|
|
Aggregated
volume
Price
|
18
Ordinary Shares
£14.5379
|
|
e)
|
Date
of the transaction
|
2023-05-11
|
|
f)
|
Place
of the transaction
|
London
Stock Exchange (XLON)
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorised.
|
|
GSK
plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May 12,
2023
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|
GSK (NYSE:GSK)
Historical Stock Chart
From Aug 2023 to Sep 2023
GSK (NYSE:GSK)
Historical Stock Chart
From Sep 2022 to Sep 2023
